Analyst Ratings For Plant Health Care plc (LON:PHC)
Today, Liberum Capital reiterated its Buy rating on Plant Health Care plc (LON:PHC).
There are 1 Buy Ratings, no Strong Buy Ratings, no Sell Ratings, no Hold Ratings on the stock.
The current consensus rating on Plant Health Care plc (LON:PHC) is Buy with a consensus target price of GBX 40 per share, a potential .
Some recent analyst ratings include
- 7/30/2018-Liberum Capital Reiterated Rating of Buy.
About Plant Health Care plc (LON:PHC)
Plant Health Care plc, together with its subsidiaries, provides patent-protected biological products for the agriculture industry in the Americas, Mexico, and rest of world. It offers products to enhance the health, vigor, and yield of field crops, such as corn, soybeans, cotton, and rice, as well as specialty crops, including fruits and vegetables. The company provides Harpin aß products comprising N-Hibit, a seed treatment application, as well as ProAct, a foliar application for row crops; and Employ, a foliar application for specialty crops. It also offers Myconate, a soil treatment that enhances mycorrhizal colonization of roots, which aids in early-stage plant growth and nutrient access; and PREtec platform that identifies families of peptides that provide that provide various agronomic benefits for farmers. In addition, the company develops bio-stimulants; and distributes complementary third-party products in Mexico. Plant Health Care plc was founded in 1995 and is based in Manchester, the United Kingdom.
Recent Trading Activity for Plant Health Care plc (LON:PHC)
Shares of Plant Health Care plc closed the previous trading session at 19.00 up +1.70 9.83% with 1.4 shares trading hands.
